Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-09-02
2008-09-02
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S300000, C514S412000, C514S421000, C540S521000, C540S523000, C540S593000, C546S113000, C548S453000
Reexamination Certificate
active
11099941
ABSTRACT:
Novel compounds that inhibit the binding of the Smac protein to Inhibitor of Apoptosis Proteins (IAPs) of the formula I
REFERENCES:
patent: 2006/0167066 (2006-07-01), Cohen et al.
patent: WO 01/90070 (2001-05-01), None
patent: WO 2004/005248 (2004-01-01), None
Stables, et al. “GR138676, A Novel Peptidic Tachykinin Antagonist Which is Potent at NK3 Receptors”, Neuropeptides (1994) 27, 333-41.
Deal, et al. “Conformationally Constrained Tachykinin Analogues: Potent and Highly Selective Neurokinin NK-2 Receptor Agonists”, J. Med. Chem. (1992) 35, 4195-4204.
Christina R. Arnt, Mihnea V. Chiorean, Michael P. Heldebrant, Gregory J. Gores, and Scott H. Kaufmann, “Synthetic Smac/DIABLO Peptides Enhance the Effects of Chemotherapeutic Agents by Binding XIAP and cIAP1 in Situ”. Journal of Biological Chemistry. 2002, vol. 277, No. 46, Nov. 15, 2002, pp. 44236-44243. JBC Papers in Press.
Rachael A. Kipp, Martin A. Case, Aislyn D. Wist, Catherine M. Cresson, Maria Carrell, Erin Griner, Arun Wiita. Phillip A. Albiniak, Jijie Chai, Yigong Shi, Martin F. Semmelhack, and George L. McLendon. “Molecular Targeting of Inhibitor of Apoptosis Proteins Based on Small Molecule Mimics of Natural Binding Partners”. Biochemistry. 2002, vol. 41, pp. 7344-7349. American Chemical Society.
Jia-Wei Wu, Amy E. Cocina, Jijie Chai, Bruce A. Hay, and Yigong Shi. “Structural Analysis of a Functional DIAP1 Fragment Bound to Grim and Hid Peptides”. Molecular Cell. 2001; vol. 8, No. 1, pp. 95-104. Cell Press.
Martyn J. Deal, Russell M. Hagan, Simon J. Ireland, Christopher C. Jordan, Andrew B. McElroy, Barry Porter, Barry C. Ross, Michaela Stephens-Smith, and Peter Ward. “Conformationally Constrained Tachykinin Analogues: Potent and Highly Selective Neurokinin NK-2 Receptor Agonists”. Journal of Medicinal Chemistry. 1992; vol. 35, pp. 4195-4204 American Chemical Society.
J. M. Stables, I. J. M. Beresford, S. Arkinstall, S. J. Ireland, D. M. Walsh, P. W. Seale, P. Ward, and R. M. Hagan. “GR138676, A Novel Peptidic Tachykinin Antagonist Which is Potent at NK3 Receptors”. Neuropeptides. 1994; vol. 27, pp. 333-341. Longman Group Ltd.
Charest Mark G.
Chen Zhuoliang
He Feng
Liu Gang
Palermo Mark Gabriel
Barker Michael P
Novartis AG
LandOfFree
Organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3919329